In a recent development on the investment in Odisha, Bharat Biotech International Ltd (BBIL) said it would manufacture 10 types of vaccines including Malaria and COVID- 19 in its upcoming unit in Odisha.
BBIL is a multi-dimensional biotechnology organisation specializing in manufacture of vaccines and bio-therapeutics. Dr Krishna Ella , Chairman and Managing Director ,BBIL announced this while attending a meeting with Odisha chief secretary A K Tripathy and other state government officials through digital medium.
The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhoea, Malaria, Japanese Encephalitis, Rabies, Pandemic Influenza and drug resistant Staphylococcus aureus, he said.
The chief secretary also asked the BBIL to set up a ‘state of art’ biotech incubation center, common facilities and IT corridor along with the first phase construction of the industry.
In BBIL’s unit at Andharua of Bhubaneswar, the company would produce 10 types of vaccines including malaria and COVID-19, he said, adding that the total investment would be around Rs 300 crore.
The chief secretary has assured BBIL that, the state government would provide all support for future expansion of the unit at Andharua in Bhubaneswar. Tripathy also directed the authorities to start the ground level construction work within a fortnight and commence production within the scheduled time.
